Press Coverage

Hepatitis C Treatment: Study Finds No Liver, Kidney or Cardiovascular Adverse Effects

June 10, 2019

Interview mentions that an ISMP QuarterWatch^TM report raising questions about whether direct acting antiviral medications for the treatment of Hepatitis C posed any significant safety risks for patients was the impetus for further study.

For the full text, visit MedicalResearch.com online.

More News

News Release 10/07/2021

ISMP Warns about Mix-Ups between Flu Vaccine and COVID-19 Vaccines

Since the 2021-2022 influenza (flu) vaccine became available in September, the Institute for Safe Medication Practices (ISMP) has received multiple reports of mix-ups. Some patients have consented to a flu vaccine but received one of the COVID-19 vaccines instead, while others have received the flue

Press Coverage 09/16/2021

The Joint Commission: Deadline for ISMP Medication Safety Self Assessment for Perioperative Settings Extended

This news brief appeared in the OR Manager newsletter on September 16, 2021.

News Release 09/14/2021

ECRI Joins Global Leaders in Supporting World Patient Safety Day 2021

ECRI and its affiliate, the Institute for Safe Medication Practices (ISMP), advocate for safe maternal and newborn care; launches site with free resources and safety guidance.